We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
-0.78%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$1.01B
AUM Growth
+$18.4M
Cap. Flow
+$33.5M
Cap. Flow %
3.3%
Top 10 Hldgs %
29.56%
Holding
285
New
19
Increased
86
Reduced
80
Closed
7

Top Buys

Rank Stock Value
1
EMR icon
Emerson Electric
EMR
+$4.54M
2
ABBV icon
AbbVie
ABBV
+$4.17M
3
MCD icon
McDonald's
MCD
+$3.64M
4
IBM icon
IBM
IBM
+$3.23M
5
DVN icon
Devon Energy
DVN
+$1.89M

Sector Composition

Rank Sector Weight
1 Energy 20.12%
2 Industrials 17.04%
3 Healthcare 14.87%
4 Technology 13.47%
5 Financials 9.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMR icon
26
Emerson Electric
EMR
$87.5B
$10.5M 1.03%
167,463
+69,950
+72% +$4.54M
CBI
27
DELISTED
Chicago Bridge & Iron Nv
CBI
$10.2M 1%
175,501
-10,743
-6% -$677K
LLTC
28
DELISTED
Linear Technology Corp
LLTC
$9.95M 0.98%
224,224
+5,519
+3% +$251K
UNP icon
29
Union Pacific
UNP
$175B
$9.95M 0.98%
91,788
+550
+0.6% +$56.9K
PVH icon
30
PVH
PVH
$3.99B
$9.77M 0.96%
80,658
-3,117
-4% -$365K
J icon
31
Jacobs Solutions
J
$16.9B
$9.48M 0.93%
234,682
-4,548
-2% -$198K
ESRX
32
DELISTED
Express Scripts Holding Company
ESRX
$8.9M 0.88%
126,036
-45,907
-27% -$3.27M
GBDC icon
33
Golub Capital BDC
GBDC
$3.39B
$8.83M 0.87%
565,475
+66,544
+13% +$1.11M
ABBV icon
34
AbbVie
ABBV
$431B
$8.74M 0.86%
151,306
+75,143
+99% +$4.17M
MU icon
35
Micron Technology
MU
$996B
$8.23M 0.81%
240,165
+5,525
+2% +$179K
JPM icon
36
JPMorgan Chase
JPM
$947B
$8.07M 0.8%
133,905
-73
-0.1% -$4.27K
WAB icon
37
Wabtec
WAB
$49.9B
$8.01M 0.79%
98,854
+4,950
+5% +$409K
PEP icon
38
PepsiCo
PEP
$189B
$7.96M 0.78%
85,473
-930
-1% -$84.9K
MCD icon
39
McDonald's
MCD
$196B
$7.96M 0.78%
83,901
+38,177
+83% +$3.64M
CELG
40
DELISTED
Celgene Corp
CELG
$7.63M 0.75%
80,482
-850
-1% -$76.7K
UPS icon
41
United Parcel Service
UPS
$87.7B
$7.62M 0.75%
77,519
+328
+0.4% +$32.6K
FLS icon
42
Flowserve
FLS
$10B
$7.58M 0.75%
107,510
-1,396
-1% -$103K
RTX icon
43
RTX Corp
RTX
$301B
$7.36M 0.73%
110,680
+540
+0.5% +$37K
CB
44
DELISTED
CHUBB CORPORATION
CB
$6.88M 0.68%
75,534
+616
+0.8% +$56.1K
EMC
45
DELISTED
EMC CORPORATION
EMC
$6.79M 0.67%
231,964
+900
+0.4% +$26K
HTLD icon
46
Heartland Express
HTLD
$952M
$6.77M 0.67%
282,597
-1,680
-0.6% -$38.9K
KO icon
47
Coca-Cola
KO
$374B
$6.53M 0.64%
153,081
-100
-0.1% -$4.13K
COF icon
48
Capital One
COF
$135B
$6.49M 0.64%
79,485
+460
+0.6% +$37.6K
BMY icon
49
Bristol-Myers Squibb
BMY
$131B
$6.26M 0.62%
122,231
+27,690
+29% +$1.38M
BRK.B icon
50
Berkshire Hathaway Class B
BRK.B
$1.13T
$6.07M 0.6%
43,940
-290
-0.7% -$38.6K

Similar funds

Neville Rodie & Shaw's Q3 2014 Portfolio in Review

As of Q3 2014, Neville Rodie & Shaw held 285 positions worth $1.01B, up 1.8% from $996M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Neville Rodie & Shaw deployed $33.5M of net new capital in Q3 2014, opening 19 new positions and adding to 86 existing holdings. Its largest new stake was Allergan plc: 5,703 shares worth $1.38M.

By sector, the portfolio is most concentrated in Energy at 20% of assets, down from 22% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Express Scripts Holding Company, an estimated $3.27M trimmed.

  • Neville Rodie & Shaw's largest Q3 2014 buy was Allergan plc: 5,703 shares worth $1.38M.
  • Neville Rodie & Shaw added most to Emerson Electric in Q3 2014, an estimated $4.54M increase.
  • Neville Rodie & Shaw's biggest Q3 2014 reduction was Express Scripts Holding Company, cutting an estimated $3.27M.
  • Neville Rodie & Shaw fully exited iShares Preferred and Income Securities ETF in Q3 2014, selling an estimated $973K.
  • Neville Rodie & Shaw's ten largest holdings make up 30% of its $1.01B portfolio in Q3 2014.
  • Neville Rodie & Shaw opened 19 new positions and closed 7 in Q3 2014.
  • Neville Rodie & Shaw's portfolio value rose 1.8% quarter-over-quarter to $1.01B.

Based on Neville Rodie & Shaw's 13F filing for Q3 2014, filed 10 Oct 2014.